Thats why we developed our ETHICS check
David Smith, urologist and co-founder of medical device company BladGo Medical, told Drugwatch
Companies such as Hengrui, Hansoh Pharmaceutical and others are now advancing their own obesity assets, not only for the domestic market but with ambitions beyond China
Check out our latest blog post for our breakdown on what makes GLP-1s unique, what to watch for in the upcoming model, and why this matters for manufacturers, payers, and policymakers alike: #CMMI #Pharmaceuticals #HealthPolicy #GLP1 #DrugPricing To view or add a comment, sign in More Relevant Posts GLP-1 therapies are transforming care and sparking major policy questions
In terms of valuation, Eli Lilly's PE - TTM on June 24 was 66x